Argenics: Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled… · Jul 29–Aug 1, 2026

New
Argenics

The campaign promotes the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, emphasizing the convenience and control of self-injection for a flexible treatment routine.

Jul 29, 2026
First seen
Aug 1, 2026
Last seen
2
Reads
2
Shows
2
Active months
31s
Avg. length

13-week activity

Public campaign reads by observed week

through Aug 3
2

Renewal signals

30 dayPending
60 dayPending
90 dayPending
Promo-code persistence

No recurring promo code was observed.

Core offer

Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe

Representative reads

Examples across the campaign

Example transcript

The read that best represents this campaign's recurring script

View promo
CNBC's "Fast Money"·Major Earnings After the Close… And the Fed Keeps Rates Unchanged 7/29/26
Est. value ~$240range $36$1.7Klow confidence
With the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, self-injection is in your hands. It's your treatment routine. Use at the time and same day each week. Take the pre-filled syringe with you on vacation or have it handy for cozy staycations. For more information, visit livevividly.com. That's L-I-V-E-V-Y-V-I-D-L-Y.com. Brought to you by Argenics.

More campaigns from Argenics

Other published campaigns from this sponsor

View all

These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.